Regarding the improved metabolic phenotype associated with loss of Slc16a13 function in our knockout mouse model, we propose the described human SLC16A13 polymorphism linked to T2D to reflect a gain-of-function mutation. The gene discussed is SLC16A13; the disease is type 2 diabetes mellitus.